 LOS ANGELES--BUSINESS WIRE--Second Sight Medical Products, Inc. NASDAQ: EYES the Company or Second Sight, a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company received a grant supplement from the National Institutes of Health NIH to fund a qualitative study to gather critical insights into how profoundly blind people weigh the risks and benefits of visual neuroprosthese 